Takara Bio Inc. (TYO:4974)
Japan · Delayed Price · Currency is JPY 1,144.00
+1.00 (0.09%)
Inactive · Last trade price on Jun 11, 2026
Takara Bio Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -9,599 | 1,997 | 2,853 | 21,224 | 27,532 |
Depreciation & Amortization | 5,321 | 4,481 | 5,021 | 4,735 | 4,149 |
Loss (Gain) From Sale of Assets | 58 | 511 | 551 | 97 | 336 |
Asset Writedown & Restructuring Costs | 3,876 | - | - | - | - |
Other Operating Activities | 376 | -11 | -2,812 | -9,245 | -5,240 |
Change in Accounts Receivable | 3,329 | -2,250 | 1,501 | 5,718 | -4,812 |
Change in Inventory | 1,072 | 102 | -324 | 13,510 | -14,233 |
Change in Accounts Payable | -305 | 1,592 | -4,367 | 139 | -431 |
Change in Other Net Operating Assets | -546 | -578 | -712 | 719 | -316 |
Operating Cash Flow | 3,582 | 5,844 | 1,711 | 36,897 | 6,985 |
Operating Cash Flow Growth | -38.71% | 241.56% | -95.36% | 428.23% | -49.90% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -12,599 | -9,871 | -12,778 | -5,747 | -12,403 |
Sale of Property, Plant & Equipment | 32 | 5 | 9 | 396 | 47 |
Cash Acquisitions | -6,416 | -546 | - | - | - |
Investment in Securities | 259 | -94 | 713 | -1,215 | 1,471 |
Other Investing Activities | 44 | -406 | -987 | -127 | 3,814 |
Investing Cash Flow | -18,680 | -10,912 | -13,043 | -6,693 | -7,071 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 9,951 | - | - | - | - |
Total Debt Issued | 9,951 | - | - | - | - |
Long-Term Debt Repaid | -213 | - | - | - | - |
Total Debt Repaid | -213 | - | - | - | - |
Net Debt Issued (Repaid) | 9,738 | - | - | - | - |
Common Dividends Paid | -2,050 | -2,048 | -5,052 | -3,968 | -1,923 |
Other Financing Activities | -1,567 | -208 | -181 | -151 | -147 |
Financing Cash Flow | 6,121 | -2,256 | -5,233 | -4,119 | -2,070 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | 104 | 1,190 | 678 | 813 | 1,008 |
Miscellaneous Cash Flow Adjustments | 49 | - | 1 | -1 | - |
Net Cash Flow | -8,824 | -6,134 | -15,886 | 26,897 | -1,148 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -9,017 | -4,027 | -11,067 | 31,150 | -5,418 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -22.36% | -8.94% | -25.44% | 39.86% | -8.00% |
Free Cash Flow Per Share | -74.88 | -33.44 | -91.91 | 258.69 | -44.99 |
Levered Free Cash Flow | -6,283 | -4,825 | -14,752 | 27,578 | -7,401 |
Unlevered Free Cash Flow | -5,920 | -4,813 | -14,737 | 27,593 | -7,386 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 70 | 20 | 22 | 24 | 23 |
Cash Income Tax Paid | 311 | -86 | 2,359 | 9,902 | 5,922 |
Change in Working Capital | 3,550 | -1,134 | -3,902 | 20,086 | -19,792 |